ALGS — ALIGOS THERAPEUTICS INC

Ownership history in HHLR ADVISORS, LTD.  ·  6 quarters on record

This page tracks every 13F SEC filing in which HHLR ADVISORS, LTD. reported a position in ALIGOS THERAPEUTICS INC (ALGS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.11% (2024 Q4)
Avg. % of fund
0.03%
First filed
2024 Q3
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 76,247 — 0% 0.02% $711K $9.32
2025 Q3 UNCHANGED 76,247 — 0% 0.02% $747K $9.80
2025 Q2 UNCHANGED 76,247 — 0% 0.02% $550K $7.21
2025 Q1 UNCHANGED 76,247 — 0% 0.02% $629K $8.25
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ALGS price (monthly, adj. close)

Other funds also holding ALGS

As of 2025 Q4 — sorted by position size

Sio Capital Management, LLC 3Y 7Y 0.49% Deep Track Capital, LP 3Y 0.07% SummitTX Capital, L.P. 0.04% Alyeska Investment Group, L.P. 3Y 7Y 0.01% Woodline Partners LP 3Y 0.01% AlphaQuest LLC 0.01% XTX Topco Ltd 3Y 0.01% BAKER BROS. ADVISORS LP 3Y 7Y 0.0% DRW Securities, LLC 3Y 7Y 0.0% Verition Fund Management LLC 3Y 7Y 0.0%
← Back to HHLR ADVISORS, LTD. Holdings